Research focuses on microbial natural products and antivirulence therapeutics. Capabilities include genome sequencing and mining, biosynthetic pathway engineering, heterologous expression, fermentation optimization, and transcriptomic screening to map mechanisms and progress leads against drug-resistant Gram-negative pathogens.